Estados Unidos - inglês - NLM (National Library of Medicine)

physicians total care, inc. - granisetron (unii: wzg3j2mcol) (granisetron - unii:wzg3j2mcol) - granisetron 3.1 mg in 24 h - sancuso® (granisetron transdermal system) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. sancuso is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch. pregnancy category b reproduction studies with granisetron hydrochloride have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, about 24 times the recommended human dose delivered by the sancuso patch, based on body surface area) and oral doses up to 125 mg/kg/day (750 mg/m2 /day, about 326 times the recommended human dose with sancuso based on body surface area). reproduction studies have been performed in pregnant rabbits at intravenous doses up to 3 mg/kg/day (36 mg/m2 /day, about 16 times the human dose with sancuso based on body surface area) and at oral doses up to 32 mg/kg/day (384 mg/m2 /day, about 167 times the human dose with san

Cingapura - inglês - HSA (Health Sciences Authority)

kyowa hakko kirin (singapore) pte. ltd. - granisetron - patch, extended release - 34.3 mg/patch

Canadá - inglês - Health Canada

sandoz canada incorporated - droperidol - solution - 2.5mg - droperidol 2.5mg - miscellaneous anxiolytics sedatives and hypnotics